Company news
Newbury Pharmaceuticals Ab (OMXSTO:NEWBRY) news
Newbury Pharmaceuticals Ab news releases on 6ix. Latest, Sep 28, 2026: Newbury Pharmaceuticals secures exclusive rights to a 40-product hospital portfolio…
Press releases & updates
Newbury Pharmaceuticals secures exclusive rights to a 40-product hospital portfolio in Iraq
September 28, 2026
Newbury Pharmaceuticals : accelerates its neuroscience ambitions with a new partnership for Guanfacine tablets
August 17, 2026
Newbury Pharmaceuticals Secures Generic Approval for Tofacitinib Newbury
July 13, 2026
Newbury Pharmaceuticals Secures Generic Approval for Dalbavancin Newbury
July 10, 2026
Newbury Pharmaceuticals Secures Generic Approval for Palbociclib Newbury
April 17, 2026
Newbury Pharmaceuticals extends and increases loan agreement to SEK 30m, convenes EGM
March 26, 2026
Newbury Pharmaceuticals has entered into a new partnership for Prucalopride tablets
March 18, 2026
Newbury Pharmaceuticals Secures 12-Month Pazopanib Tender in Denmark
January 29, 2026
Newbury Pharmaceuticals publishes its annual report for 2024/2025
December 10, 2025
Newbury Pharmaceuticals appoints its founder Karl Karlsson as new CEO
November 11, 2025
Newbury Pharmaceuticals Secures Generic Approval for Mirtazapin Newbury
October 24, 2025
Newbury Pharmaceuticals Secures Generic Approval for Ivermectin Newbury
October 23, 2025
Newbury Pharmaceuticals Secures Generic Approval for Melatonin Newbury
August 11, 2025
Newbury Pharmaceuticals carries out a directed share issue of approximately SEK 16 million and extends the existing SEK 15 million loan agreement
April 28, 2025
Newbury Pharmaceuticals Secures Generic Approval for Pazopanib Newbury
April 16, 2025
Newbury Pharmaceuticals expands its portfolio with four new products
March 19, 2025
Newbury Pharmaceuticals Secures Approval for Macitentan film-coated tablets
March 14, 2025
Newbury Pharmaceuticals Secures Generic Approval for Pomalidomide capsules
January 24, 2025
Newbury Pharmaceuticals Secures Generic Approval for Bosutinib tablets
January 22, 2025